Methotrexate nephrotoxicity: a pragmatic approach

Identification of emerging risk factors, advances in pharmacogenomics, and timely methotrexate monitoring, combined with patient-specific pharmacokinetic modeling, underscore the importance of personalized therapeutic strategies to reduce renal toxicity and DME.

Authors

Institutions

Publication Details

Journal
Current Opinion in Nephrology & Hypertension
Published
2025-12-05
DOI
https://doi.org/10.1097/mnh.0000000000001144
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Methotrexate nephrotoxicity: a pragmatic approach

Jaya Kala, Yara Mouawad
Current Opinion in Nephrology & Hypertension
Acute Lymphoblastic Leukemia research
article

Methotrexate nephrotoxicity: a pragmatic approach

Jaya Kala, Yara Mouawad
article en

Abstract

Identification of emerging risk factors, advances in pharmacogenomics, and timely methotrexate monitoring, combined with patient-specific pharmacokinetic modeling, underscore the importance of personalized therapeutic strategies to reduce renal toxicity and DME.

Current Opinion in Nephrology & HypertensionVol. 35(2)
The University of Texas Health Science Center (US)
Openalex Percentile: Top 50%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Methotrexate nephrotoxicity: a pragmatic approach — Jaya Kala, Yara Mouawad · Current Opinion in Nephrology & Hypertension (2025) | TGRS Research Map | TGRS